Events

  • EpiVax Immunogenicity Seminar – September 17th 2014 at the Westin Tokyo

    EpiVax Immunogenicity Seminar – September 17th 2014 at the Westin Tokyo

    Posted on May 12, 2014 by Annie De Groot
    EpiVax will be in Tokyo Japan from September 14th-20th, 2014 hosting our semiannual immunogenicity seminar and meeting with collaborators. The Westin Immunogenicity Seminar is scheduled for September 17th, 2014. The purpose of this seminar is to bridge the gap between recent academic research on Tregs, Tregitopes and protein drug development (immunogenicity, deimmunization and tolerance induction). Links PDF Agenda Last year’s event ...
    Read more
  • Participate in the 4th Computational Vaccinology Workshop at ISV

    Participate in the 4th Computational Vaccinology Workshop at ISV

    Posted on May 9, 2014 by Annie De Groot
    On October 25th EpiVax will be hosting the Computational Vaccinology Workshop at ISV. This marks the 4th year of the Computational Vaccinology Worskhop, previously known as ICoVax, a pre-conference workshop to the 8th International Vaccine and ISV Congress, which will be held October 26-28th, 2014 in Philadelphia, PA. Featuring oral presentations, posters and hands-on software demonstrations, ...
    Read more
  • Hands on iVAX Training at Vaccine Technology V Riviera Maya Mexico

    Hands on iVAX Training at Vaccine Technology V Riviera Maya Mexico

    Posted on April 29, 2014 by Annie De Groot
    EpiVax is attending and presenting at the “Vaccine Technology V” conference in the Mexican Riviera. June 8-13, 2014 Paradisus Hotel Playa del Carmen, Mexico Conference Website Register Here Click the picture below to download a PDF flyer.   EpiVax will also host a hands-on training workshop. Learn how to use EpiVax’s unique vaccines design software, iVAX. *workshop description coming soon. Learn more about iVAX ...
    Read more
  • EpiVax Attending PEGS Boston

    EpiVax Attending PEGS Boston

    Posted on April 29, 2014 by Annie De Groot
    EpiVax will be attending PEGS in Boston May 5-9th, 2014 and presenting 1 poster. Over 1,600 participants will gather in Boston’s vibrant seaport district for open forum discussions and collaboration at CHI’s flagship biologics event “PEGS the essential protein engineering summit”. The continued success of PEGS is driven by the growth in biologics worldwide, the quality ...
    Read more
  • De Groot to speak at ASCLS-CNE event

    De Groot to speak at ASCLS-CNE event

    Posted on April 24, 2014 by Annie De Groot
    APRIL 24, 2014 EpiVax CEO/CSO, Dr. Annie De Groot MD, will be one of the featured speakers during next week’s 66th Annual Clinical Laboratory Science Convention. The event is scheduled for April 29 through May 1 at the Rhode Island Convention Center in Providence. Dr. De Groot will speak on Tuesday, April 29 during a workshop on ...
    Read more
  • Immunogenicity and Tolerance Seminar - Amsterdam 2016

    Immunogenicity and Tolerance Seminar – Amsterdam 2016

    Posted on April 1, 2014 by Annie De Groot
    Platine ​and ​EpiVax are ​co-organizing ​their ​2nd ​seminar on Immunogenicity and Tolerance on October 24th, 2016. Click this link to register This meeting will focus on the determinants of immunogenicity – a key feature of effective vaccines and a key barrier to success in the clinic for protein therapeutics. Conversely, tolerance induction is a key feature of successful protein therapeutics, while ...
    Read more
  • EpiVax at the Coral Gables Symposium, Understanding Immunogenicity 2014

    EpiVax at the Coral Gables Symposium, Understanding Immunogenicity 2014

    Posted on March 27, 2014 by Annie De Groot
    EpiVax’s BDA, Anthony Marcello is attending the Coral Gables Symposium: Understanding Immunogenicity 2014, and will be presenting 3 posters, see below: Antigen-specific tolerance induction by Tregitopes in vivo. In silico High Throughput Pre-clinical Determination of Monoclonal Antibody Immunogenicity Immunogenic Biologics: Validation of Screening, Deimmunization and Tolerization Approaches The 2014 Coral Gables Symposium will focus on an understanding of the ...
    Read more
  • Join us in Nice!

    Join us in Nice!

    Posted on March 26, 2014 by Annie De Groot
    The 9th International Congress on Autoimmunity has kicked off! We are looking forwards to the presentations over the next 5 days, sure to be insightful and innovative. If you haven’t heard EpiVax is hosting Tregitope Nice – a scientific symposium entitled “Tregitopes and Tregs in Autoimmunity” on Saturday, March 29th. Meet us at 10:30 in the ...
    Read more
  • EpiVax Eurotrip Spring 2014

    EpiVax Eurotrip Spring 2014

    Posted on February 11, 2014 by Annie De Groot
    Aah, Europe! EpiVax is taking a Euro trip this spring, but no, we won’t be roughing it in hostels – we’ll be at conferences and meeting with our EU-based partners, working on collaborations that aim to make protein therapeutics safe, vaccines effective and develop innovative solutions to immunogenicity problems. First stop – Amsterdam to meet Phoebe ...
    Read more
  • Partner with us at BIO Europe March 10th-12th in Turin

    Partner with us at BIO Europe March 10th-12th in Turin

    Posted on February 11, 2014 by Annie De Groot
                Looking for an opportunity to meet with Dr. Anne De Groot and learn more about EpiVax? We will be attending the BIO Europe Spring conference in Turin, March 10th through 12th. We are very excited to meet new groups within the vast European biotech circle. If you know EpiVax, you know we work with a ...
    Read more
  • Dr. Lenny Moise to Speak at World Vaccine Congress 2014

    Dr. Lenny Moise to Speak at World Vaccine Congress 2014

    Posted on January 29, 2014 by Annie De Groot
    Dr. Lenny Moise, Director of Vaccine Research EpiVax, Inc., Providence, RI, United States Talk Title: Immunome-Derived Vaccines: The next wave in vaccine design March 26th, 2014 @ 12:20  Conference Website Here Lenny Moise, PhD is Director of Vaccine Research at EpiVax, Inc. Dr. Moise received his PhD from the Department of Molecular and Cellular Biology and Biochemistry at Brown University ...
    Read more
  • Dr. Anne De Groot Speaking at GTC Bio

    Dr. Anne De Groot Speaking at GTC Bio

    Posted on December 12, 2013 by Annie De Groot
    Dr. Anne De Groot has been invited to speak at the GTC 2nd Immunogenicity and Immunotoxicity Conference January 30-31st in San Diego, CA. This conference is one of four co-located conferences for the Novel Immunotherapeutics Summit 2014 and focuses on important progress made in the ares of therapeutic protein immunogenicity and immunotoxicity evaluation and mitigation. Learn ...
    Read more
  • Don't Miss! Free Webinar on Epitope Driven Vaccines by Anne De Groot

    Don’t Miss! Free Webinar on Epitope Driven Vaccines by Anne De Groot

    Posted on November 21, 2013 by Annie De Groot
    Interested in learning more about innovative technologies in vaccine development? Dr. Anne De Groot, CEO/CSO of EpiVax, will be giving a FREE webinar lecture entitled “Designing an epitope-driven vaccine for a “stealth virus” – H7N9 case study“, generously hosted by DNAvaccine.com. Her lecture will explore the principles and applications of epitope-driven vaccines, using H7N9 as a case study.  Join us on December 6th ...
    Read more
  • EpiVax at Biotech Showcase, January 2014

    EpiVax at Biotech Showcase, January 2014

    Posted on November 20, 2013 by Annie De Groot
    EpiVax is excited to announce that we will be attending the 6th Annual Biotech Showcase in San Francisco, January 13th to 15th. We will be engaging in partnering sessions and will be featuring our own innovative technology platforms, including ISPRI for best in class protein immunogenicity screening, iVAX our web-based gene-to-vaccine design platform, and Tregitope, our novel immunomodulatory molecule. ...
    Read more
  • Annie De Groot to Speak at ASHI on Tregitopes, Tolerance and Transplantation

    Annie De Groot to Speak at ASHI on Tregitopes, Tolerance and Transplantation

    Posted on November 18, 2013 by Annie De Groot
    EpiVax’ very own Dr. Annie De Groot is an invited speaker at the ASHI annual meeting this week. She will be providing a talk on the morning of Tuesday, November 19th,  2013 during the 39th annual meeting of American Society for Histocompatibility and Immunogenetics (ASHI) (https://www.ashi-hla.org/) to be held in Sheraton Chicago Hotel & Towers, ...
    Read more
  • EpiVax Attending Immunogenicity Summit in DC - Presenting 3 Posters!

    EpiVax Attending Immunogenicity Summit in DC – Presenting 3 Posters!

    Posted on November 4, 2013 by Annie De Groot
    EpiVax will be attending the upcoming Immunogenicity Summit in DC. EpiVax’ BDA, Anthony Marcello, will be presenting 3 posters (see below) on behalf of the EpiVax science team. Additionally, one of EpiVax’ Tregitope collaborators, Dr. David W. Scott, will be giving an exciting talk about tolerization approaches to FVIII therapy. Posters:  Antigen-specific tolerance induction by Tregitopes in vivo Immunogenic ...
    Read more
  • Tregitope Europe at the 9th International Congress on Autoimmunity in Nice

    Tregitope Europe at the 9th International Congress on Autoimmunity in Nice

    Posted on November 1, 2013 by Annie De Groot
    We are pleased to announce that EpiVax is hosting the “Tregitope Europe” meeting in conjunction with the 9th International Congress on Autoimmunity in Nice, France on March 26th 2014. The meeting will consist of a 120 minute scientific session as part of the main conference dedicated to research and technology for treg based immune modulation. Tregitope Europe continues ...
    Read more
  • Dr. De Groot Presenting CHOPPI in Basel at 6th Workshop on Monoclonal Antibodies

    Dr. De Groot Presenting CHOPPI in Basel at 6th Workshop on Monoclonal Antibodies

    Posted on September 11, 2013 by Annie De Groot
    Dr. Annie De Groot is an invited speaker at the 6th Workshop on Monoclonal Antibodies in Basel, Switzerland, on September 12th, 2013. She will presenting information on CHO host cells proteins (HPC’s) and their effects on the immunogenicity of biologics. She will also present information regarding the CHOPPI website, a free online immunogenicity screening tool ...
    Read more
  • The 3rd ISV Pre-conference Computational Vaccinology Workshop (ICoVax 2013)

    The 3rd ISV Pre-conference Computational Vaccinology Workshop (ICoVax 2013)

    Posted on September 10, 2013 by Annie De Groot
    Introduction: The annual Vaccine & ISV Annual Global Congress, co-organized by the Vaccine journal and the International Society for Vaccines (ISV), is the largest non-commercial conference in the vaccine field and attended by vaccine experts and researchers around the world. The journal Vaccine (https://www.journals.elsevier.com/vaccine/) is the pre-eminent journal for those interested in vaccines and vaccination.  ISV ...
    Read more
  • 4th Immunoinformatics and Computational Immunology Workshop (ICIW)

    4th Immunoinformatics and Computational Immunology Workshop (ICIW)

    Posted on September 6, 2013 by Annie De Groot
    4th Immunoinformatics and Computational Immunology Workshop EpiVax will be the 4th ICIW this year! We will be presenting posters and extensive iVAX and ISPRI demos. We hope to see you there. EpiVax Accepted Posters (PDF’s linked): A.S. De Groot, P. Bertino, P. Hoffman, M. Carbone, A.G. Siccardi, F. Terry, L.P. Cousens, L. Moise, and W. Martin. Highly Immunogenic ...
    Read more
  • 7th Vaccine Renaissance Conference - Abstracts Due Sept 15

    7th Vaccine Renaissance Conference – Abstracts Due Sept 15

    Posted on August 22, 2013 by Annie De Groot
    Registration is now open and abstracts are being accpeted, for 7th Annual Vaccine Renaissance Conference Providence, RI Registration is now open for iCubed’s seventh annual Vaccine Renaissance Conference. The conference is slated for October 16-18, 2013 in Providence, Rhode Island. Abstracts are being accepted and the deadline is September 15th – send 250 word abstract to Patrick Lowney ...
    Read more
  • Westin Immunogenicity Seminar Osaka 2013

    Westin Immunogenicity Seminar Osaka 2013

    Posted on July 19, 2013 by Annie De Groot
    Dr. Annie De Groot will be in Japan from October 7th – 11th, to meet with collaborators and to host a semi-annual seminar on immunogenicity. The purpose of this seminar is to bridge the gap between recent academic research on Tregs, Tregitopes and protein drug development (immunogenicity, tolerance induction). Full Agenda Here – 議題 Please check this page for updates. To ...
    Read more
  • EpiVax at 8th AED 2013, Boston

    EpiVax at 8th AED 2013, Boston

    Posted on June 10, 2013 by Annie De Groot
    8th Antibody Engineering and Discovery Conference – AED 2013 EpiVax’s Anthony Marcello will be attending the 8th Antibody Engineering and Discovery Conference in Boston, MA from 7/24/13 – 7/25/13. Also, we are presenting 7 posters! See below to download our posters. Location: Boston, MA – Revere Hotel, Boston Common, 200 Stuart Street Boston, MA 02116 Antigen-specific tolerance induction by Tregitopes in vivo. Tregitopes: The active ...
    Read more
  • EpiVax at USP June 3-4

    EpiVax at USP June 3-4

    Posted on June 3, 2013 by Annie De Groot
    Measurement of Residual Host Cell Protein and DNA in Biotechnology Products Work Shop On Monday, June 3rd at 2:35 PM EpiVax’s CEO/CSO Dr. Annie De Groot presented a talk on the Immunogenicity Analysis of CHOP Contaminants in Therapeutic Protein Formulations. The workshop was hosted by USP and BEBPA, and designed specifically for the biopharmaceutical industry. The meeting ...
    Read more
  • EpiVax Immunogenicity Seminar - Westin Tokyo 2013

    EpiVax Immunogenicity Seminar – Westin Tokyo 2013

    Posted on May 15, 2013 by Annie De Groot
    EpiVax was in Japan from May 8th – 15th hosting our semiannual immunogenicity seminar. The ‘Westin Immunogenicity Seminar’ was a great success. Thank you to all the wonderful speakers and attendees that made our seminar possible. We are looking forward to our following visit in the Fall, probably in late October, for our next meeting. We will keep you all up-to-date on our ...
    Read more
  • Annie De Groot on Pandemic Influenza Vaccines at the 11th Annual EID and Biodefense meeting.

    Annie De Groot on Pandemic Influenza Vaccines at the 11th Annual EID and Biodefense meeting.

    Posted on May 11, 2013 by Annie De Groot
    EpiVax will be at the 11th Annual EID and Biodefense Meeting, June 17-19, 2013 at the Almas Temple Club, Washington, DC. Dr. Annie De Groot will be joining a panel of vaccine and influenza experts to discuss pandemic universal influenza vaccines. See EID and Biodefense Agenda Here Panel: Towards Universal Pandemic Influenza Vaccines Influenza has officially moved into epidemic status for 2013. Work towards ...
    Read more
  • 7th Vaccine & ISV Congress, ICoVax 2013 & EpiVax Cocktail Reception in Spain!

    7th Vaccine & ISV Congress, ICoVax 2013 & EpiVax Cocktail Reception in Spain!

    Posted on May 7, 2013 by Annie De Groot
    EpiVax will be in Sitges, Spain October 26th – 29th. We will be attending the 7th Vaccine & ISV Congress where we will be sponsoring an ‘EpiVax Welcome Cocktail Reception‘ on Sunday the 27th. Come join us for a time to connect, network and enjoy a cocktail in beautiful Sitges, Spain. We will also be attending the ...
    Read more
  • Immunopathology of T1D & Advances in the Knowledge and Treatment of Autoimmunity - Whistler BC - April 4-9

    Immunopathology of T1D & Advances in the Knowledge and Treatment of Autoimmunity – Whistler BC – April 4-9

    Posted on March 26, 2013 by Annie De Groot
    Immunopathology of T1D & Advances in the Knowledge and Treatment of Autoimmunity – Whistler BC – April 4-9 EpiVax’s Dr. Leslie Cousens will be attending Keystone’s Immunogpathology of T1D conference this April. She will be presenting a poster depicting some fascinating data relating to T1D and Tregitopes! Check out the links below: EpiVax_T1D_Keystone_Conference_Poster_25Mar13 Poster Number: 1011 Poster Title: Application of Tregitopes for tolerance induction ...
    Read more
  • Fourth Immunoinformatics and Computational Immunology Workshop (ICIW 2013)

    Fourth Immunoinformatics and Computational Immunology Workshop (ICIW 2013)

    Posted on March 22, 2013 by Annie De Groot
    Fourth Immunoinformatics and Computational Immunology Workshop (ICIW 2013) September 22, 2013 DoubleTree by Hilton Hotel Bethesda – Washington DC, USA, in conjunction with ACM-BCB, September 22-25, 2013 EpiVax will be making a stop in DC this September at the ICIW Workshop 2013! EpiVax’s propriety in-silico platforms embody the essence of  “Bridging Immunology and Computer Science” by enabling drug developers to design more effective vaccines and safer biologics. We hope to see you ...
    Read more
  • Immunogenicity Seminar 2013 - Tokyo, Japan

    Immunogenicity Seminar 2013 – Tokyo, Japan

    Posted on March 19, 2013 by Admin Epivax
    Dr. Annie De Groot will be in Japan from May 8th – 15th, to meet with collaborators and host a semi-annual seminar on immunogenicity. Please see below for details. Sign Up Here! (フォームを登録) –  PDF Agenda (議題) Immunogenicity Seminar 2013 Sponsored by: The Institute for Immunology and Informatics (iCubed), University of Rhode Island & EpiVax, Inc. Venue: The Westin Tokyo – Kiri Room Thursday, May ...
    Read more
  • Hawaii-tope at AAI!

    Hawaii-tope at AAI!

    Posted on March 12, 2013 by Annie De Groot
    SAVE THE DATE! EpiVax is hosting a cocktail reception at University of Hawaii’s new Cancer Center (at the Sullivan Center), Sunday May 5th, 5:30 – 8:30 pm! Hawaii-tope will be a cocktail and appetizer reception sponsored by EpiVax and the venue was generously donated by Dr. Michele Carbone, Director of UHCC. If you are attending the AAI conference or will be in the area, please come and ...
    Read more
  • Tregitope West Seminar at AAPS!

    Tregitope West Seminar at AAPS!

    Posted on March 11, 2013 by Annie De Groot
    Tregtiope West was a great success! We would like to say ‘thank you’ to all of our speakers and to all those who attended. We had a wonderful turnout and your participation is very much appreciated. See below for a digital copy of the handouts and links to our posters. Click Here For Full Agenda Full Tregitope West Printout ...
    Read more
  • Biowarfare Experts Speak in Providence

    Biowarfare Experts Speak in Providence

    Posted on October 15, 2012 by Annie De Groot
    Bioterror is the real threat. At the most recent joint US-Korea wargames, held on the border of North and South Korea, biowarfare was one of the threats introduced, to which allied forces had little to no defense. That exercise drove home the importance of biowarfare preparedness, and the military is currently scrambling to get up ...
    Read more
  • Summiting on Immunogenicity and Epitope Networks

    Summiting on Immunogenicity and Epitope Networks

    Posted on October 11, 2012 by Annie De Groot
    EpiVax is attending the Immunogenicity Summit in Bethesda this week. Look for Leslie and Annie in person (Annie is usually at the microphone asking questions about HLA associations). We will be piloting some new slides on Epitope Networks. (For more on that, see the link to our CHO/Host Cell protein talk, which is also available ...
    Read more
  • Hands On Vaccine Design in Yokohama

    Hands On Vaccine Design in Yokohama

    Posted on October 3, 2012 by Annie De Groot
    Modern Genome-Based Vaccine Design Sponsored by: EpiVax & iCubed Venue: Pacifico Yokohama: 1-1-1, Minato Mirai, Nishi-ku, Yokohama, Japan  Friday November 16th, 9:00 am – 5:00 pm Speakers: Dr. Hiroshi Kiyono M.D. Professor and Dean, Institute of Medical Science, University of Tokyo Dr. Annie De Groot M.D. Professor and Director, Institute of Immunology and Informatics, University of Rhode Island CEO/CSO, EpiVax  Dr. Takuya Tsunoda, M.D., Ph.D. President & CEO OncoTherapy Science, ...
    Read more
  • Tregitope World Tour Fall 2012

    Tregitope World Tour Fall 2012

    Posted on October 2, 2012 by Annie De Groot
    Our Tregitope tour continues this month and on through the fall including stops in Orlando, Bethesda and Yokohama. Take a look at the list below and let us know if you’d like us to visit you while we’re in the area. ICIW 2012 Tutorial Session 10/7 – 10/10 In conjunction with: ACM International Conference on Bioinformatics and Computational ...
    Read more
  • EpiVax to attend ICIW 2012

    EpiVax to attend ICIW 2012

    Posted on July 26, 2012 by Annie De Groot
    The Third Immunoinformatics and Computational Immunology Workshop will be held in conjunction with the ACM International Conference on Bioinformatics and Computational Biology in Orlando, FL on October 7-10 2012. The main theme of this meeting is “Bridging Immunology and Computer Science“. Nowadays computational methods are integral to virtually every research and development project in every discipline. ...
    Read more
  • Tregitope Wins Big SBIR Program

    Tregitope Wins Big SBIR Program

    Posted on April 9, 2012 by Annie De Groot
    Providence-based biotech EpiVax, Inc. was awarded a new NIH SBIR Phase II grant totaling $1.5M in funding from the National Institutes of Health’s (NIH) NIDDK to explore formulation, dose, route and delivery vehicle for Tregitope through the NIH Small Business Innovation Research (SBIR) program. EpiVax anticipates receiving an additional SBIR award of approximately $775,000 within ...
    Read more
  • Srini Kaveri to discuss IVIG and Tregitope MOA at 4th Tregitope Update

    Srini Kaveri to discuss IVIG and Tregitope MOA at 4th Tregitope Update

    Posted on April 2, 2012 by Annie De Groot
    The 4th Annual Tregitope update will be held in Baltimore Maryland on April 20th, 2012 (Click here for more information). Dr. Srini Kaveri of the Centre de Recherche des Cordeliers (INSERM) in Paris will provide an update on the mechanism of action of IVIG with an eye to parallels with Tregitope. A wide range ...
    Read more
  • Save the Date - 6th Vaccine Renaissance, Providence Rhode Island

    Save the Date – 6th Vaccine Renaissance, Providence Rhode Island

    Posted on March 31, 2012 by Annie De Groot
    EpiVax is a proud sponsor of the 6th Annual Vaccine Renaissance Conference scheduled for October 15-17, 2012 in Providence, Rhode Island.
    Read more
  • Updated list of Immunogenicity and Tregitope Talks 2012

    Updated list of Immunogenicity and Tregitope Talks 2012

    Posted on March 20, 2012 by Annie De Groot
    Where will we be in Spring 2012? Click here to hear about our latest research and cutting edge approaches to immunogenicity solutions. . .
    Read more
  • Westin Immunogenicity Seminar March 16th

    Westin Immunogenicity Seminar March 16th

    Posted on March 4, 2012 by Annie De Groot
    The Westin Seminar is back! Join us in Tokyo on March 16th to discuss immunogenicity risk and mitigation.
    Read more
  • Spring 2012 Immunogenicity Workshop Schedule

    Spring 2012 Immunogenicity Workshop Schedule

    Posted on February 3, 2012 by Annie De Groot
    Come participate in one of the following hands-on demonstrations of our bioinformatics tools!  Each of these workshops features presentations and demonstrations led by our expert immunoinformaticians. Learn from the best! Hands-on Workshops! 5th Antibody Generation, Engineering & Design Conference Frankfurt, Germany Le Meridien Parkhotel, Frankfurt, Germany 29th of February 2012 Half-Day Workshop February 29th: Latest Advances in Reducing the Risk of ...
    Read more
  • Happy New Year! Tregitope World Tour 2012

    Happy New Year! Tregitope World Tour 2012

    Posted on January 1, 2012 by Annie De Groot
    It’s a New Year (2012) and our resolution is to keep you better informed. Here’s a list of our upcoming conferences. . . .
    Read more
  • Westin Immunogenicity Seminar September 27 2011, Tokyo, Japan

    Westin Immunogenicity Seminar September 27 2011, Tokyo, Japan

    Posted on September 5, 2011 by Annie De Groot
    Westin Immunogenicity Seminar 2011 Tuesday, September 27, 2011 9:45 am – 6:10 pm Kiri Room The Westin Tokyo 1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan Speakers: Annie De Groot M.D. Director and Professor, Institute of Immunology and Informatics,University of Rhode Island and CEO/CSO EpiVax; Frances Terry, Immunoinformatics / Bioinformatics Specialist, EpiVax, Inc. Keizo Yoshida Ph.D., EpiVax Asia   9: 00 – 9 :45  AM Registration / Breakfast 9: ...
    Read more
  • Tregitope World Tour 2011

    Tregitope World Tour 2011

    Posted on August 16, 2011 by Annie De Groot
    Tregitope offers an opportunity to rethink protein therapeutics, immunogenicity and tolerance. Evidence is accumulating that Tregitopes are the ‘natural off switch’, leading to suppression of inflammatory T cell responses, and modulating the phenotype of antigen presenting cells. Learn more about Tregitope by participating in the following conferences where the collective work of the Tregitope researchers ...
    Read more
  • Immunogenicity and Vaccine Talks 2011

    Immunogenicity and Vaccine Talks 2011

    Posted on March 26, 2011 by Annie De Groot
    Come hear the latest updates on better proteins and vaccines by design – See our list of speaking engagements and appearances here:
    Read more
  • Immunogenicity: Determinants and Correlates

    Immunogenicity: Determinants and Correlates

    Posted on March 5, 2011 by Annie De Groot
    A ‘don’t-miss’ meeting of academic researchers, immunologists, and industry scientists gathering to discuss in silico, in vitro and in vivo drivers of human immune response. The meeting is followed by a hands-on training in immunoinformatics (TRIAD Toolkit) and the annual Tregitope meeting (discussion of tolerance-inducing Tregitope).
    Read more
  • Agenda for Immunogenicity Determinants and Correlates Conference

    Agenda for Immunogenicity Determinants and Correlates Conference

    Posted on March 5, 2011 by Annie De Groot
    Agenda for Immunogenicity Determinants and Correlates Conference – Valid as of March 05, 2011
    Read more
  • 4th Tregitope Update - Open Meeting May 11 2011

    4th Tregitope Update – Open Meeting May 11 2011

    Posted on February 13, 2011 by Annie De Groot
    Tregitopes are small peptidic regulatory T-cell epitopes derived from human immunoglobulins that activate regulatory T cells (Tregs). Tregitope therapy has broad-reaching implications, offering new treatments for autoimmune diseases (e.g. type 1 juvenile diabetes, multiple sclerosis, rheumatoid arthritis, and lupus), allergies, and transplantation rejection. In previous meetings, the members of the Tregitope Collaborators team have demonstrated ...
    Read more